Drug General Information
Drug ID
D00TQR
Former ID
DNC003746
Drug Name
1-Methyl-3-propyl-3,7-dihydro-purine-2,6-dione
Drug Type
Small molecular drug
Indication Discovery agent Investigative [526756]
Formula
C9H12N4O2
Canonical SMILES
CCCN1C2=C(C(=O)N(C1=O)C)NC=N2
InChI
1S/C9H12N4O2/c1-3-4-13-7-6(10-5-11-7)8(14)12(2)9(13)15/h5H,3-4H2,1-2H3,(H,10,11)
InChIKey
MCPROACZLSAAPY-UHFFFAOYSA-N
PubChem Compound ID
Target and Pathway
Target(s) Type IV phosphodiesterase Target Info Inhibitor [526756]
CAMP-specific 3',5'-cyclic phosphodiesterase 4A Target Info Inhibitor [526756]
KEGG Pathway Purine metabolism
cAMP signaling pathway
Morphine addictionhsa00230:Purine metabolism
Morphine addiction
PathWhiz Pathway Purine Metabolism
Reactome DARPP-32 events
G alpha (s) signalling eventsR-HSA-180024:DARPP-32 events
G alpha (s) signalling events
WikiPathways G Protein Signaling Pathways
Myometrial Relaxation and Contraction Pathways
TSH signaling pathwayWP35:G Protein Signaling Pathways
References
Ref 526756J Med Chem. 1992 Oct 30;35(22):4039-44.Effects of alkyl substitutions of xanthine skeleton on bronchodilation.
Ref 526756J Med Chem. 1992 Oct 30;35(22):4039-44.Effects of alkyl substitutions of xanthine skeleton on bronchodilation.